Results 81 to 90 of about 13,603 (206)
Novos conhecimentos sobre a doença de Vogt-Koyanagi-Harada [PDF]
, 2009 Vogt-Koyanagi-Harada disease (VKH), a well-established multiorgan disorder affecting pigmented structures, is an autoimmune disorder of melanocyte proteins in genetically susceptible individuals.
BEZERRA, Felipe Theodoro +4 more
core +2 more sources
The Potential of Phytochemicals to Overcome Multidrug Resistance in Metastatic Melanoma
Chemistry &Biodiversity, Volume 23, Issue 1, January 2026.ABSTRACT Metastatic melanoma is the most lethal form of skin cancer, accounting for most skin cancer‐related deaths. Immunotherapies and targeted therapies have improved overall and progression‐free survival rates in metastatic melanoma patients. The effectiveness of these therapies decreases due to multidrug resistance (MDR).
Jacqueline Maphutha +4 more
wiley +1 more source
Choroidal melanoma in a 49-year-old female
Philippine Journal of Ophthalmology, 2005 Objective: To describe a case of choroidal melanoma. Methods: This is a case report. Results: A 49-year-old female complained of blurring of vision in the right eye of five months duration.
Maria Joanna Rodriguez-Chan, MD +4 more
doaj
Beyond Treatment: The Strategy of Nonintervention in Choroidal Hemangioma
Clinical Case Reports, Volume 14, Issue 1, January 2026.ABSTRACT The circumscribed choroidal hemangioma (CCH) is a benign congenital eye tumor whose etiology is not clear. A 41‐year‐old female patient came with a 2‐year history of slowly progressive deteriorating vision in her right eye. In the left eye, the best‐corrected visual acuity (BCVA) was 6/6, and counting fingers at 1 m in the right eye.
Humdan Khan +8 more
wiley +1 more source
Indian Journal of Ophthalmology, 2014 Vitrectomy and endoresection is an alternative to enucleation for the treatment of large malignant choroidal melanoma. We report a rare case of extensive recurrence of choroidal malignant melanoma with extraocular extension 11 years after surgical ...
Mehdi Modarres +2 more
doaj +1 more source
Proton Therapy for Uveal Melanoma in 43 Juvenile Patients: Long-Term Results. [PDF]
, 2014 PURPOSE: To examine the metastatic and survival rates, eye retention probability, and the visual outcomes of juvenile patients after proton beam radiotherapy (PBRT) for uveal melanoma (UM).
Bergin, C. +4 more
core +1 more source
Journal of Magnetic Resonance Imaging, Volume 63, Issue 1, Page 142-154, January 2026.ABSTRACT Background Atypical glioblastoma (GBM) (minimal or no necrosis on MRI) and primary central nervous system lymphoma (PCNSL) are difficult to distinguish on MRI; whether tumor habitat can more accurately distinguish atypical GBM from PCNSL remains uncertain.
Meng‐nan Sun +12 more
wiley +1 more source
Randomised clinical trials of choroidal melanoma treatment.
Indian Journal of Ophthalmology, 2003 Purpose: To illustrate an approach to evidence-based medical practice by reporting the Collaborative Ocular Melanoma Study (COMS) randomised clinical trials and cohort studies of choroidal melanoma.
Straatsma Bradley
doaj
Concomitant Choroidal Melanoma and Non-Hodgkin Lymphoma in Two Adult Patients: Case Report
Case Reports in Ophthalmology, 2012 Objective: To report two cases of concomitant choroidal melanoma and intraocular non-Hodgkin lymphoma in two patients. Design: Case report. Participants: Two patients with yellow creamy infiltrates in fundo.
Marcel Vlaskamp +3 more
doaj +1 more source
Mass spectrometry in ocular drug research
Mass Spectrometry Reviews, Volume 45, Issue 1, Page 37-68, January/February 2026.Abstract Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments.
Eva M. del Amo +6 more
wiley +1 more source